Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Feire Kechuan Oral Solution is a traditional Chinese medicine (TCM) herbal oral liquid developed by Sunflower Pharmaceutical Group. It is formulated based on classic TCM prescriptions, specifically Maxing Shigan Decoction and Baihu Decoction, and contains 11 herbal ingredients including Ephedra (Mahuang), bitter apricot seed (Kuxingren), gypsum (Shigao), licorice (Gancao), honeysuckle (Jinyinhua), Forsythia (Lianqiao), Anemarrhena (Zhimu), Scutellaria (Huangqin), Isatis root (Banlangen), Ophiopogon (Maidong), and Houttuynia (Yuxingcao). It is approved and marketed in China for the treatment of pediatric respiratory tract infections, including influenza, bronchitis, and Mycoplasma pneumoniae pneumonia (often in combination with azithromycin). The solution exhibits broad-spectrum antibacterial and antiviral activities, reduces inflammatory cytokines (such as IL-6, IL-8, and TNF-α), and alleviates symptoms like fever, cough, sputum, and wheezing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoer Feire Kechuan Oral Solution.